NTLA Stock Predictions

Recent NTLA Stock Price   NTLA Stock Predictions
$51.46 NTLA stock predictions: higher
 As of 2022-12-01
Recent NTLA Analyst Ratings Breakdown, Making NTLA Stock Predictions
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 16 15 16 15
Buy ratings: 2 2 1 1
Hold ratings: 2 2 2 2
Sell ratings: 0 0 0 0
Strong sell ratings: 1 1 1 0
Average rating: 1.45 1.48 1.45 1.28
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.

For the NTLA stock predictions from the analysts covering Intellia Therapeutics Inc, we have collected all of the individual NTLA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 19 different analysts covering NTLA (as reported in data provided by Zacks Investment Research via Quandl.com).

But since NTLA stock predictions may vary widely, another useful metric to consider is the median NTLA stock prediction, which represents the price at which half of the analysts made NTLA stock predictions that were higher and half made NTLA stock predictions that were lower. This makes for a different take on the NTLA stock predictions out there, as compared to average or mean. And that median across all the individual NTLA stock predictions was: $114.0 as of 2022-12-01.

The very highest of the NTLA stock predictions for one year price target was $180.0, while the very lowest of the NTLA stock predictions in the analyst group was $50.0 (with a standard deviation of $39.684). Get the latest Zacks research report on NTLA — FREE

Find out: NTLA next earnings date »

Slideshow Dividend Growth Stocks: 25 Aristocrats
Slideshow 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did

Other stock predictions:
 • AER Stock Predictions
 • IBM Stock Predictions
 • SPFI Stock Predictions
 • KFY Stock Predictions
 • MSFT Stock Predictions
 • FIX Stock Predictions
 • CNTG Stock Predictions
 • THS Stock Predictions
 • JAMF Stock Predictions

Intellia Therapeutics Inc
Quotes delayed 20 minutes
Email EnvelopeFree NTLA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.55 out of 4)
60th percentile
(ranked higher than approx. 60% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com


NTLA Stock Predictions | www.TopDividends.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in this site or parent site DividendChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.